ASR Vermogensbeheer’s AstraZeneca AZN Stock Holding History

ASR Vermogensbeheer’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$162M	Buy	862,996 +21,075	+3%	+$3.96M	1.66%	10
2026 Q1	$163M	Buy	+841,921	New	+$162M	1.92%	7

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ASR Vermogensbeheer's AZN Position: Q2 2026 in Review

ASR Vermogensbeheer increased its AstraZeneca (AZN) stake by 2.5% in Q2 2026, buying an estimated $3.96M and bringing the position to 862,996 shares worth $162M. The position accounts for 1.66% of the portfolio, ranked #10.

ASR Vermogensbeheer first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $163M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

ASR Vermogensbeheer held 862,996 shares of AstraZeneca worth $162M as of Q2 2026.
ASR Vermogensbeheer bought 21,075 AstraZeneca shares in Q2 2026, an estimated $3.96M.
AstraZeneca made up 1.66% of ASR Vermogensbeheer's portfolio in Q2 2026, its #10 holding.
ASR Vermogensbeheer first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
ASR Vermogensbeheer's AstraZeneca position peaked at $163M in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.